Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 113 clinical trials
Sputum Microbiota and the Association With Clinical Parameters in Steady-state Acute Exacerbation and Convalescence of Bronchiectasis

Study 1 is a cross-sectional investigation. Patients with clinically stable bronchiectasis (symptoms, including cough frequency, sputum volume and purulence, within normal daily variations) will undergo baseline assessment consisting of history taking, routine sputum culture, 16srRNA pyrosequencing, measurement of sputum inflammatory markers, oxidative stress biomarkers and MMPs, and spirometry. Microbiota taxa …

cough
grip
sputum culture
antibiotic therapy
spirometry
  • 29 views
  • 23 Jan, 2021
  • 1 location
PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial (PFOX)

The fibrotic interstitial lung diseases (fILD) are characterised by lung scarring, distressing breathlessness and poor health-related quality of life. Exertional desaturation (low blood oxygen during exercise) is a hallmark of fILD, occurring in over 50% of patients. It is sometimes treated with ambulatory oxygen therapy (AOT), which involves breathing supplemental …

  • 3 views
  • 12 Feb, 2022
  • 1 location
High Intensity Interval Training in Fibrotic Interstitial Lung Disease (HIIT in fILD)

The fibrotic interstitial lung diseases (fILD) is a group of debilitating chronic lung conditions that are characterised by scarring of lung tissue, dyspnoea on exertion and significant physical impairment. Exercise training is recommended for people with fILD in improving breathlessness and exercise tolerance. However, despite the best efforts of patients …

  • 65 views
  • 15 Feb, 2022
  • 2 locations
CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

in subjects with idiopathic pulmonary fibrosis (IPF).

idiopathic pulmonary fibrosis
  • 0 views
  • 05 Jun, 2022
  • 10 locations
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF). There is a 48-week randomized treatment phase followed by an optional, open-label extension phase.

idiopathic pulmonary fibrosis
pamrevlumab
nintedanib
carbon monoxide
diffusion capacity of the lung for carbon monoxide
  • 63 views
  • 29 May, 2022
  • 96 locations
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

participants with idiopathic pulmonary fibrosis.

diffusion capacity of the lung for carbon monoxide
idiopathic pulmonary fibrosis
nintedanib
pirfenidone
  • 45 views
  • 15 Jun, 2022
  • 38 locations
  • 23 views
  • 16 Jun, 2022
  • 91 locations
A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis (STARSCAPE)

with idiopathic pulmonary fibrosis (IPF).

walk tests
nintedanib
lung biopsy
carbon monoxide
diffusion capacity of the lung for carbon monoxide
  • 18 views
  • 16 Jun, 2022
  • 286 locations
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis

This is an interventional double-blind randomized controlled trial, to investigate the short and long-term effects of a supervised exercise training program in patients with IPF, depending on alternate patterns of oxygen supplementation during PR.

idiopathic pulmonary fibrosis
pulmonary rehabilitation
pirfenidone
nintedanib
  • 162 views
  • 30 Jan, 2022
  • 1 location
Jaktinib Dihydrochloride Monohydrate in Idiopathic Pulmonary Fibrosis

Jaktinib Dihydrochloride Monohydrate for idiopathic pulmonary fibrosis

idiopathic pulmonary fibrosis
acetylcysteine
  • 27 views
  • 10 Dec, 2021
  • 1 location